- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Multiple Endocrine Neoplasia Type 1 in India
Total 716 results
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Canada, India, Romania, Spain, Mexico, Turkey, Portugal, Egypt
-
PfizerCompletedCarcinoma, Pancreatic DuctalUnited States, Netherlands, Canada, Hungary, Spain, United Kingdom, France, Austria, Belgium, Germany, Ireland, Korea, Republic of, Russian Federation, Sweden, South Africa, Italy, Singapore, Taiwan, Australia, India, Argentina, J... and more
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Netherlands, Portugal, Spain, Turkey, India, Austria, Egypt, Greece, Israel, Mexico, United Kingdom, Korea, Republic of, Hong Kong, Colombia, Lebanon
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Netherlands, Portugal, Spain, India, Austria, Egypt, Greece, Israel, Mexico, United Kingdom, Korea, Republic of, Hong Kong, Colombia, Lebanon
-
Karyopharm Therapeutics IncActive, not recruitingMultiple MyelomaUnited States, United Kingdom, Australia, Israel, Canada, Belgium, Austria, Czechia, Serbia, India, France, Italy, Russian Federation, Bulgaria, Germany, Greece, Hungary, Poland, Romania, Spain, Ukraine
-
ShireCompletedGaucher Disease, Type 1Spain, Israel, United States, India, Paraguay, United Kingdom, Russian Federation, Tunisia, Argentina
-
NovartisCompletedDiabetes Mellitus, Type 2Spain, Argentina, Russian Federation, Norway, India, Sweden, Finland, France, Canada, Germany, Australia, Costa Rica
-
Immune Oncology Research InstituteRecruitingEmbryonal TumorArmenia, Hungary, Canada, Peru, Iran, Islamic Republic of, Italy, Taiwan, India, Mexico
-
Inovio PharmaceuticalsCompletedCervical Intraepithelial NeoplasiaSouth Africa, United States, Korea, Republic of, Canada, Estonia, India, Georgia, Australia, Puerto Rico
-
Hoffmann-La RocheCompletedOvarian CancerFrance, Spain, Sweden, Hong Kong, Canada, Switzerland, Estonia, Greece, Russian Federation, Hungary, Austria, Bulgaria, Netherlands, Latvia, Italy, Slovenia, Turkey, Serbia, Israel, Argentina, Brazil, Slovakia, Lithuania, Poland, Portugal, Mexi... and more
-
Novartis PharmaceuticalsCompletedCushing's DiseaseItaly, Belgium, Japan, Germany, United Kingdom, Thailand, Spain, France, Netherlands, Turkey, Israel, China, United States, Canada, India, Argentina, Brazil, Peru, Poland, Russian Federation
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, United Kingdom, Australia, Canada, Thailand, India
-
PhenomixForest LaboratoriesTerminatedType 2 Diabetes Mellitus | Type 2 DiabetesUnited States, Malaysia, Peru, India, Argentina, Philippines, Romania, Ukraine
-
Titan PharmaceuticalsCompletedCarcinoma, Non-Small-Cell LungUnited States, India, United Kingdom
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Japan, India, Puerto Rico, Mexico
-
CelgeneWithdrawnMultiple MyelomaChina, Australia, United States, Argentina, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Germany, Greece, Hungary, India, Ireland, Italy, Japan, Korea, Republic of, Norway, Portugal, Romania, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
International Atomic Energy AgencyTata Memorial Centre; University of Maryland, College Park; Centro de Lucha contra... and other collaboratorsUnknownSquamous Cell Carcinoma of the Head and NeckIndia, Argentina, Cuba, Indonesia, Pakistan, Philippines, South Africa, Thailand, Uruguay
-
CelgeneRecruitingMultiple MyelomaAustria, Italy, China, Australia, Spain, United States, Korea, Republic of, Taiwan, Germany, Ireland, Argentina, Brazil, Mexico, Netherlands, Belgium, Czechia, France, Greece, Japan, Poland, Israel, United Kingdom, Norway, Denmark, Finland and more
-
PhenomixForest LaboratoriesTerminatedType 2 Diabetes MellitusUnited States, Argentina, India, Peru, Poland, Czech Republic
-
PfizerRecruitingMultiple MyelomaJapan, Belgium, United States, Netherlands, Australia, Austria, Taiwan, China, Spain, Canada, Israel, Germany, Italy, Czechia, Korea, Republic of, Norway, Finland, France, Sweden, Brazil, Greece, Turkey, United Kingdom, Hungary, Poland, I...
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingMedullary Thyroid CancerUnited States, Canada, Spain, China, Taiwan, Australia, Japan, India, Belgium, Germany, France, Netherlands, Czechia, Brazil, Korea, Republic of, United Kingdom, Italy, Israel, Greece, Poland, Russian Federation
-
Onconova Therapeutics, Inc.Academic GI Cancer Consortium (AGICC)CompletedMetastatic Pancreatic AdenocarcinomaUnited States, India, Russian Federation, Hungary, Ukraine
-
Bristol-Myers SquibbRecruitingMultiple MyelomaCanada, Taiwan, United States, Australia, Denmark, China, Korea, Republic of, Israel, Spain, France, Germany, Czechia, Austria, Japan, Sweden, United Kingdom, Greece, Italy, Finland, Argentina, Belgium, Brazil, Colombia, Hong Kong, India, Mexic... and more
-
AstraZenecaRecruitingOvarian CancerChina, Vietnam, Russian Federation, Ukraine, South Africa, Turkey, India, Peru, Colombia, Poland, Chile, Philippines
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited Arab Emirates, Malaysia, India, South Africa, Algeria, Lebanon
-
Eli Lilly and CompanyRecruitingDiabetes Type 2United States, India, Mexico, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSaudi Arabia, Algeria, Argentina, Bangladesh, China, Egypt, India, Indonesia, Iran, Islamic Republic of, Jordan, Korea, Republic of, Libyan Arab Jamahiriya, Malaysia, Mexico, Morocco, Pakistan, Philippines, Russian Federation and more
-
SanofiCompletedDiabetes Mellitus, Type 2Algeria, Colombia, Egypt, Guatemala, India, Iran, Islamic Republic of, Lebanon, Mexico, Russian Federation, South Africa, Tunisia, Turkey, Ukraine, United Arab Emirates
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited States, Canada, Mexico, India, Puerto Rico, Russian Federation, South Africa
-
Novartis PharmaceuticalsRecruitingDifferentiated Thyroid CancerTurkey, Malaysia, Korea, Republic of, Taiwan, India, Vietnam, Argentina, China, Canada, United States, Brazil, Mexico
-
AstraZenecaCompletedChronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell LymphomaIndia
-
CymaBay Therapeutics, Inc.CompletedType 2 DiabetesUnited States, Israel, Argentina, India
-
AstraZenecaQuintiles, Inc.CompletedType 2 DiabetesUnited States, Korea, Republic of, India, Russian Federation, Brazil, Mexico, South Africa, Philippines
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, South Africa, Canada
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 2Puerto Rico, Spain, United States, India, Brazil
-
International Atomic Energy AgencyPostgraduate Institute of Medical Education and Research; Ege University; Dr... and other collaboratorsCompletedGlioblastoma MultiformeArgentina, Belarus, Brazil, Canada, Chile, Estonia, Georgia, India, Indonesia, Ireland, Poland, Thailand, Tunisia, Turkey
-
Hoffmann-La RocheCompletedPancreatic CancerAustralia, Hong Kong, Romania, Germany, Russian Federation, United Kingdom, Bulgaria, Malaysia, Latvia, Slovenia, Croatia, Brazil, Italy, Lithuania, India, Mexico, Singapore, Peru, Ukraine
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Mexico, India
-
MorphotekEisai Europe Ltd. (United Kingdom)TerminatedOvarian CancerUnited States, Hong Kong, Netherlands, Spain, Korea, Republic of, Belgium, Taiwan, Israel, Japan, France, United Kingdom, Singapore, Italy, Argentina, India, Germany, Hungary, Australia, Portugal, Russian Federation, Canada, Poland, Greec... and more
-
CENTOGENE GmbH RostockWithdrawnChronic Kidney Disease | Hearing Loss | Angiokeratomas | Ocular AbnormalitiesSri Lanka, India, Germany
-
Glenmark Specialty S.A.RecruitingLymphoma | Advanced Solid TumorUnited States, India
-
Eli Lilly and CompanyCompletedType 2 DiabetesChina, Australia, Korea, Republic of, India
-
PfizerCompletedType 2 Diabetes MellitusUnited States, Hungary, Taiwan, Romania, India, South Africa, Philippines, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Serbia, Bulgaria, Australia, Korea, Republic of, Thailand, Turkey, United Arab Emirates, Hungary
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisUnited States, Canada, China, Spain, Italy, France, Slovenia, Japan, Turkey, Argentina, Estonia, Greece, Mexico, Poland, Sweden, Croatia, South Africa, Brazil, Slovakia, Bulgaria, Romania, India, Portugal, United Kingdom, Puerto Rico
-
Hoffmann-La RocheCompletedRenal Cell Carcinoma | Chronic Myelogenous Leukemia | Malignant MelanomaCanada, India, Bulgaria, Russian Federation, Spain, South Africa, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Korea, Republic of, China
-
Cadila PharnmaceuticalsCompleted
-
AstraZenecaDaiichi Sankyo Co., Ltd.RecruitingPart 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer | Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerCanada, Korea, Republic of, Taiwan, United States, Italy, United Kingdom, Thailand, Russian Federation, India, Belgium, Australia, Poland, Spain, Japan, Brazil, Czechia, Netherlands
-
Genzyme, a Sanofi CompanyCompletedGaucher Disease, Type 1United States, United Kingdom, Bulgaria, Canada, Colombia, India, Israel, Lebanon, Mexico, Russian Federation, Serbia, Tunisia